ACO Name and Location

Privia Quality Network, LLC
950 N Glebe RdSuite 700
Arlington, VA 22203

ACO Primary Contact

Deepa Achutuni
571-451-0058
Deepa.achutuni@priviahealth.com

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture
Anchor Healthcare PLC N
Annandale OB GYN N
Arlington ENT Associates, P.C. N
Bay West Endocrinology Associates PA N
Bethesda Allergy & Asthma Clinic, LLC N
Betsy Vasquez N
Bayside Internal Medicine, LLC N
Charlottesville Family Medicine, PC N
Churchland Family Medicine, PC N
Claudia Methvin, MD, PLLC N
Coastal Obstetrics & Gynecology N
Cal Arundel Family Medicine, LLC N
Carlos E Covarrubias, MD & Associates, LLC N
Catonsville Primary Care Center, P.A. N
Central Virginia Family Physicians, Inc. N
Comprehensive Neurology And Sleep Medicine, P.A. N
Denise Chevalier Hamilton N
Downtown Family Healthcare Inc N
Drs Gabbay Feldman & Pearlman PA N
Danville Internal Medicine, INC N
Drs Maggin Margolis Moy and Tadikonda Llc N
Eye Physicians of Virginia, LTD. N
Family Medical Care, Inc. N
Fork Union Family Medicine N
Favero Family Practice Incorporated N
Frederick Primary Care Associates, P.A. N
GP Therapy, LLC N
Greenway Endocrinology, P.A. N
Gregory C. Mathews, MD, LLC N
Heart and Vascular Specialists, PC N
IPS of Winchester, LCC N
Immaculate Medical Services, LLC N
Lauren Rodgers, MD, PC N
Lawrence Miller N
Marina Shores OB GYN N
Matthew S. Kaatz, M.D., P.C. N
Mount Vernon Internal Medicine N
Newbridge Spine and Pain Center LLC N
Newbridge Spine and Pain Center of Virginia LLC N
Paul B Cannon DPM PC N
Pulmonologists PC N
Privia Medical Group LLC N
Richard A. De Santis, PH.D., M.D., P.C. N
Robert C Blackwood MD Inc N
Rockbridge Health, PLLC N
Rose Hill Family Physicians, LLC N
Santa D’Alessio MD PC N
Star Family Medicine N
Virginia Head and Neck Surgeons PC N
Virginia Womens Center Inc N
William Linthicum N

ACO Governing Body:

Member Member’s Voting Power –Expressed as a percentage or number Membership Type ACO Participant Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Taweel Fred Chairman 1/12 ACO Participant  Privia Medical Group LLC
Belford Jane Director 1/12 Beneficiary Representative  
Bernstein Jeffrey Director 1/12 ACO Participant Privia Medical Group LLC
Beyer Eric Director 1/12 Other  
Bicksel James Director 1/12 ACO Participant Privia Medical Group LLC
Eppes Thomas Director 1/12 ACO Participant Privia Medical Group LLC
Huang Caroline Director 1/12 ACO Participant  Privia Medical Group LLC
Khetan Shishir Director 1/12 ACO Participant  Privia Medical Group LLC
Meshulam Joel Director 1/12 ACO Participant Privia Medical Group LLC
Mushtaq Ednan Director 1/12 ACO Participant Privia Medical Group LLC
Sexton  Sumi Director 1/12 ACO Participant Privia Medical Group LLC
Zimmet Steve Director 1/12 ACO Participant Privia Medical Group LLC

Key ACO Clinical and Administrative Leadership:

ACO Executive: Eric Beyer
Medical Director: Fred Taweel
Compliance Officer: Dana Fields
Quality Assurance/Improvement Officer: David West

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
Clinical IT Committee Jarret Dodd, Chair
Clinical Performance Committee David West, Chair
Compliance Committee Dana Fields, Chair
Credentialing Committee Steve Zimmet, Chair
Engagement Committee Corey Perdue, Chair
Finance Committee Fred Taweel, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangements
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance Year 2020, $42,266,717
  • Second Agreement Period
    • Performance Year 2019, $16,998,165
    • Performance Year 2018, $20,066,830
    • Performance Year 2017, $18,079,932
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $6,156,225
    • Performance Year 2014, $2,793,592

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2018
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2017
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2014
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%

Quality Performance Results

2020 Quality Performance Results:

ACO Quality Measure Number Measure Name Rate ACO Mean
ACO-43 Ambulatory Sensitive Condition Acute Composite 0.80 .95
ACO-13 Falls: Screening for Future Fall Risk 95.56 84.97
ACO-14 Preventive Care and Screening: Influenza Immunization 83.48 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 81.82 81.67
ACO-18 Preventive Care and Screening: Screening for Depression and Follow-up Plan 59.38 71.46
ACO-19 Colorectal Cancer Screening 70.49 72.59
ACO-20 Breast Cancer Screening 70.00 74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 84.84 83.37
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 15.25 14.70
ACO-28 Hypertension (HTB): Controlling High Blood Pressure 78.80 72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.